RG

Ramakrishna Guduru

Active Director Director DIN 09464093
DIN 09464093 First appointment Jan 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2022
Shareholding value •••• Premium profile

About Ramakrishna Guduru

Data last updated:

Ramakrishna Guduru is a Director at Zasya Life Sciences Private Limited (since 2022) and Director at Neovant Therapeutics Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹12.03 Cr; the largest is Zasya Life Sciences Private Limited at ₹9.37 Cr (FY 2025).

DIN 09464093
Primary Designation Director
Industry Pharma
First Appointment 13 Jan 2022
Oldest Company Age 5 yrs
Largest company Zasya Life Sciences Private Limited · ₹9.37 Cr (FY 2025)
Combined revenue ₹12.03 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zasya Life Sciences Private Limited U73100GJ2021PTC126759
Director13 Jan 20222021₹9.37 Cr (FY 2025)Active
Neovant Therapeutics Private Limited U21002GJ2023PTC138826
Director10 Mar 20232023₹2.66 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Zasya Life Sciences Private Limited
Neovant Therapeutics Private Limited
Premium access

Shareholding and investment profile for Ramakrishna Guduru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramakrishna Guduru

Ramakrishna Guduru currently holds 2 directorships: Zasya Life Sciences Private Limited (Director, since 13 Jan 2022, revenue ₹9.37 Cr (FY 2025)); Neovant Therapeutics Private Limited (Director, since 10 Mar 2023, revenue ₹2.66 Cr (FY 2025)).

Ramakrishna Guduru was first appointed on 13 Jan 2022 as Director at Zasya Life Sciences Private Limited. The most recent appointment on record is 10 Mar 2023 at Neovant Therapeutics Private Limited.

The 2 current companies of Ramakrishna Guduru that report revenue have a combined latest revenue of ₹12.03 Cr: Zasya Life Sciences Private Limited ₹9.37 Cr (FY 2025); Neovant Therapeutics Private Limited ₹2.66 Cr (FY 2025).

The current boards of Ramakrishna Guduru's companies include Dilip Shankarbhai Chaudhary (Zasya Life Sciences Private Limited), Nirav Pravinkumar Trivedi (Zasya Life Sciences Private Limited), Ramaswamy Akula (Zasya Life Sciences Private Limited), Siddhanand Narendranath Padukone (Zasya Life Sciences Private Limited), Dashrathbhai Kalidas Patel (Neovant Therapeutics Private Limited), Jagdish Madhavlal Chaudhary (Neovant Therapeutics Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available